Medibio has announced study results indicating an 80% PTSD diagnosis rate of their objective mental health diagnostic. The company’s test is breaking into the market of noninvasive mental healthcare. Medibio partnered with Emory University to develop a classifier based on measures of heart rate and heart rate variability to differentiate between patients with and without PTSD. Read the full article here.